News
Migraine nearly doubles the amount of healthcare visits and sick-leave days
8.4.2019
In a collaborative study between Medaffcon, Novartis and Terveystalo the burden of disease of migraine ...
Migraine nearly doubles the amount of healthcare visits and sick-leave days
14.3.2019
New real-world evidence (RWE) based study shows that migraine nearly doubles the amount of healthcare ...Finnish pricing and reimbursement landscape
25.2.2019
Pharmaceuticals Pricing Board (PPB), operating under the Ministry of Social Affairs and Health, evaluates reimbursement ...
Medaffcon’s article in the latest biobanking magazine
9.1.2019
Medaffcon pioneering biobank and real-world evidence research efforts in Finland The newest Biobanking in Finland ...
Medaffcon on Twitter
12.04.2019 6:52
Read the newest press release: PHOENIX group Finnish subsidiary Medaffcon pioneers #biobank research. #RWE - https://t.co/1MLjN9C3a7
Read the newest press release: PHOENIX group Finnish subsidiary Medaffcon pioneers #biobank research. #RWE - https://t.co/1MLjN9C3a7
04.04.2019 6:20
"Suomi voi olla digitalisaation ja terveysalan kärkimaa, mutta rohkeutta se vaatii" #terveys #RWD #digitalisaatio https://t.co/5OZbsW5xLo
"Suomi voi olla digitalisaation ja terveysalan kärkimaa, mutta rohkeutta se vaatii" #terveys #RWD #digitalisaatio https://t.co/5OZbsW5xLo
27.03.2019 9:54
Saimme kunnian isännöidä Turun biolääketieteen opiskelijoiden ainejärjestön (In Vitro Aboensis ry) yritysvierailua viime perjantaina. #biolääketiede #harjoittelu #yritysvierailu https://t.co/YAzsqgTB5L
Saimme kunnian isännöidä Turun biolääketieteen opiskelijoiden ainejärjestön (In Vitro Aboensis ry) yritysvierailua viime perjantaina. #biolääketiede #harjoittelu #yritysvierailu https://t.co/YAzsqgTB5L
